Hepion Pharmaceuticals Announces Early Completion of Enrollment in Phase 2 'ALTITUDE-NASH' Liver Function Trial

Stock Information for Hepion Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.